Lv1
48 积分 2026-04-30 加入
Interstitial lung disease in patients treated with antibody–drug conjugates: a review
1天前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
3个月前
已完结
皖公网安备34019202002308
